Michael Friedman serves as the Senior Director of Device and System Engineering at AstraZeneca, where he plays a pivotal role in advancing the company’s inhalation organization. With over 17 years of experience in the medical device sector, Michael has consistently demonstrated his commitment to enhancing...
Michael Friedman serves as the Senior Director of Device and System Engineering at AstraZeneca, where he plays a pivotal role in advancing the company’s inhalation organization. With over 17 years of experience in the medical device sector, Michael has consistently demonstrated his commitment to enhancing patient outcomes through innovative device systems. His leadership encompasses a broad spectrum of responsibilities, including overseeing Design Controls for Software as a Medical Device (SaMD), Core Engineering, Risk Management, and Human Factors, ensuring that all aspects of device development meet stringent regulatory and quality standards.
In his current role, Michael leads a consolidated global device function, driving the end-to-end development of both early-stage device projects and late-stage combination products. His expertise in medical device product development is complemented by a strong foundation in Quality Management and Validation processes, which are critical to the successful launch of safe and effective medical devices. Michael is also passionate about fostering cross-functional team leadership, collaborating with diverse stakeholders to streamline processes and enhance project outcomes.
A champion of lean continuous improvement initiatives, Michael is dedicated to optimizing workflows and reducing waste within the device development lifecycle. His strategic planning skills enable him to identify opportunities for innovation while maintaining a focus on regulatory compliance and risk mitigation. Through his extensive experience in root cause analysis and validation, Michael ensures that AstraZeneca remains at the forefront of medical device innovation, ultimately making a meaningful difference in the lives of patients around the world.
